As of May 2025, over 10,168 lawsuits have been filed in the federal Multidistrict Litigation (MDL 3060) in Illinois, with thousands more pending in state courts. Key developments include:
Philadelphia Mass Tort Program (May 2025): A new mass tort program has been established in Philadelphia, offering an alternative to the federal MDL.
Discovery Progress (May 2025): Fact discovery is underway for 32 bellwether cases, with trials expected in 2026-2027.
L’Oréal SA Dismissal (May 2025): The French parent company was dismissed from the MDL, but U.S.-based L’Oréal USA remains a key defendant.
Settlement Mediator Appointed (April 2025): A special master has been assigned to facilitate settlement discussions, though no global settlement is imminent.
You may qualify for a hair relaxer lawsuit if you:
Used chemical hair relaxers frequently (4+ times per year for several years).
Were diagnosed with:
Uterine cancer
Endometrial cancer
Ovarian cancer
Uterine fibroids requiring hysterectomy
Used products from major brands like L’Oréal, Dark & Lovely, ORS Olive Oil, or Just for Me.
Statute of Limitations: Varies by state, but most follow the "discovery rule," meaning the clock starts when you link your cancer to hair relaxer use.
Get a Free Case Evaluation to see if you qualify.
Major companies facing lawsuits include:
Brand
Parent Company
Dark & Lovely
L’Oréal USA
ORS Olive Oil
Namaste Labs
Just for Me
Godrej Consumer Products
Motions
Strength of Nature
Optimum Salon
Revlon (in bankruptcy)
Other defendants include Avlon, John Paul Mitchell Systems, and Wella.
Uterine & Endometrial Cancer
Risk: Women using relaxers 4+ times/year had 2.5x higher risk (NIH Sister Study, 2022).
Some lawsuits allege relaxers contributed to severe fibroids requiring surgery.
NIH Sister Study (2022): Found 2.5x higher uterine cancer risk in frequent users.
Silent Spring Institute (2018): 84% of hair products for Black women contained endocrine-disrupting chemicals (EDCs).
Environmental Research (2023): Confirmed long-term relaxer use increases uterine cancer risk in postmenopausal women.
While no settlements have been reached yet, projected payouts based on similar mass tort cases:
Injury Type
Estimated Settlement Range
Uterine Cancer
$150,000 – $750,000
Ovarian Cancer
$200,000 – $1,000,000
Severe Fibroids (Hysterectomy)
$100,000 – $500,000
Factors affecting payouts:
Age at diagnosis (younger plaintiffs may receive more).
Extent of medical treatment.
Proof of product use & causation.
How to File a Hair Relaxer Lawsuit
Consult an Attorney: Free case reviews determine eligibility.
Gather Evidence: Medical records, product usage history.
File a Claim: Your lawyer handles paperwork and litigation.
Negotiation/Trial: Most cases settle, but some may go to trial.
Why Choose Us? ✔ Nationwide representation ✔ No fees unless you win ✔ Proven track record in mass torts
Contact Us for a Free Consultation
If you or a loved one developed uterine cancer, ovarian cancer, or severe fibroids after using chemical hair relaxers, you may be entitled to compensation. With over 10,000 lawsuits filed, manufacturers are facing increasing pressure to settle.
Get a Free Case Review Today – Time may be limited to file.
Frequently asked questions
Likely late 2025 or early 2026, after bellwether trials.
No, they are individual lawsuits consolidated in an MDL.
Yes, if you meet the eligibility criteria.
Proving causation, but strong scientific studies support claims.
No, Revlon has insurance coverage for these claims.
Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.